{"product_id":"nutraceuticals-9780128210383","title":"Nutraceuticals","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003eSection I. Applications of nutraceuticals in common diseases and disorders  1. Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection  2. Prevention of neurodegenerative disorders by nutraceuticals  3. Cognitive effects of nutraceuticals  4. Nutraceuticals in anxiety and stress  5. Countering cardiovascular diseases with nutraceuticals  6. Nutraceuticals for diabetes and glucose balance  7. Role of nutraceuticals in respiratory and allied diseases  8. Nutraceuticals in hepatic diseases  9. Nutraceuticals in renal diseases  10. Nutraceuticals in gastrointestinal disorders  11. Nutraceuticals in reproductive and developmental disorders  12. Nutraceuticals in ophthalmic diseases  13. Nutraceuticals in dermal diseases 14. Nutraceuticals in arthritis  15. Nutraceuticals in sports activities and fatigue  16. Role of nutraceuticals as adaptogens  17. Nutraceuticals for weight loss  18. Nutraceuticals in cancer prevention 19. Application of “nano” nutraceuticals in medicine  Section II. Models and mechanisms in evaluation of nutraceuticals  20. The biology of nutrients: genetic and molecular principles  21. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals  22. Transcriptomic profiling for safety and toxicity evaluation of nutraceuticals  23. Target identification and polypharmacology of nutraceuticals  24. Systems pharmacology investigation of mechanism of action of nutraceuticals 25. Noninvasive in vivo optical imaging models for safety and toxicity testing  26. Flow cytometry and light-scattering techniques in evaluation of nutraceuticals  27. Zebrafish as a model system to evaluate the safety and toxicity of nutraceuticals 28. Caenorhabditis elegans: an elegant model organism for evaluating the neuroprotective and neurotherapeutic potential of nutraceuticals  29. Alternative in vitro models for safety and toxicity evaluation of nutraceuticals 30. Mitochondria as a target for safety and toxicity evaluation of nutraceuticals 31. Oxidative stress and excitotoxicity: antioxidants from nutraceuticals Section III. Common nutraceuticals 32. Caffeine: an evaluation of the safety database  33. Biological activities and potential nanotechnological delivery of resveratrol  34. Melatonin: a safe nutraceutical and clinical agent 35. Standardized turmeric and curcumin  36. Curcuminoid-metal complexes for oxidative stress 37. Fenugreek: multiple health benefits 38. Cannabis sativa: an overview 39. Cannabidiol safety 40. St John’s wort (Hypericum perforatum L) 41. Green tea  42. Green coffee beans 43. Quercetin 44. German chamomile  45. Isoflavones: toxicological aspects and efficacy   46. Propolis  47. Bee products as nutraceuticals to nutraceuticals for bees  48. Ginkgo biloba  49. Chinese ginseng  50. Ashwagandha: multiple health benefits  51. Astaxanthin: health benefits and toxicity  52. Thymoquinone  53. Glucosinolates 54. Organosulfur compounds as nutraceuticals 55. Arginine and citrulline as nutraceuticals: efficacy and safety in diseases  56. Neem Extract 57. Spirulina  58. Garcinia cambogia  59. Vitamin E TPGS and its applications in nutraceuticals 60. Role of transferrin: an iron-binding protein in health and diseases  61. Glutamine supplementation: hope, hype, or stay tuned?  62. What to do with placenta after birth: is it a waste?  63. Chitin, chitosan, and their derivatives  Section IV. Prebiotics and probiotics  64. Prebiotics: safety and toxicity considerations 65. Probiotics: safety and toxicity considerations 66. Synbiotics: safety and toxicity considerations  Section V. Nutraceuticals in veterinary medicine  67. Nutraceuticals in animal health and diseases  Section VI. Toxicity and toxic interactions  68. Toxic contamination of nutraceuticals and food ingredients  69. Nutraceuticals and adverse outcome pathways  70. Interactions between nutraceuticals\/nutrients and nutrients and therapeutic drugs  71. Genotoxicity evaluation of nutraceuticals  Section VII. Regulatory aspects  72. The regulatory framework for nutraceuticals: North America 73. Evaluation and regulation of food supplements: European perspective 74. Regulatory guidelines for nutraceuticals in India: an overview  75. Regulatory aspects of nutraceuticals: Chinese perspective 76. Uses and regulation of nutraceuticals: Australia and New Zealand  77. Regulatory aspects of nutraceuticals: Japanese perspective 78. Nutraceuticals: the Turkish perspective","brand":"Elsevier Science Publishing Co Inc","offers":[{"title":"Default Title","offer_id":49399839261015,"sku":"9780128210383","price":139.5,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780128210383.jpg?v=1730468875","url":"https:\/\/bookcurl.com\/products\/nutraceuticals-9780128210383","provider":"Book Curl","version":"1.0","type":"link"}